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background:  To determine access site related bleeds and vascular complications after access site closure using either the Proglide (PG) 
or Prostar (PS) suture mediated closure device after transfemoral aortic valve implantation (TAVI).
methods:  In this large multicenter registry we analyzed a total of 1001 patients undergoing TAVI using either the Proglide (n= 593) or 
Prostar (n=408) closure devices. Closure device failure and complications were defined according to the Valve Academic Research 
Consortium-2 (VARC-2) criteria.
results:  Compared to PS group patients in the PG group were younger (81.9±7.2 vs. 80.4±9.1, p=<0.01) without differences regarding 
gender (women 56.5% vs. 56.8%, p=0.97). Distribution of different valve types was significantly different between 2 groups with Corevalve 
as most frequently implanted valve in PS group (69%) and Sapien in PG group (54%), p=<0.001. No differences were observed in the 
rate of post-TAVI minor access site bleeds and device failure (1.4% vs. 2.0%, p=0.45). Significantly more VARC-2 access site vascular 
complications and life-threatening/disabling bleeds with haemoglobin drop ≥5 g/dl requiring more than 4 units of blood transfusion occurred 
in the PS group (Figure).
Conclusion:  Use of PG closure device increase the safety of TAVI compared to the PS closure device.
 
